SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Accounting Policies [Abstract] |
|
| SCHEDULE OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
The
Company considers all highly liquid securities with original maturities of three months or less when acquired, to be cash equivalents.
The Company’s cash composition was as follows:
SCHEDULE
OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH
| | |
December 31, 2025 | | |
December 31, 2024 | |
| | |
| | |
| |
| Cash and cash equivalents | |
$ | 8,052,621 | | |
$ | 12,639,441 | |
| Restricted cash | |
| 2,050,000 | | |
| 2,861,054 | |
| Total cash, cash equivalents and restricted cash | |
$ | 10,102,621 | | |
$ | 15,500,495 | |
|
| SCHEDULE OF INVENTORY |
SCHEDULE
OF INVENTORY
| | |
December 31, 2025 | | |
December 31, 2024 | |
| Inventory, component parts | |
$ | 2,413,821 | | |
$ | 1,901,922 | |
| Inventory, finished goods | |
| 3,136,347 | | |
| 3,183,424 | |
| Allowance | |
| (1,300,000 | ) | |
| (1,300,000 | ) |
| Inventory-total | |
$ | 4,250,168 | | |
$ | 3,785,346 | |
|
| SCHEDULE OF ANTI-DILUTIVE COMMON STOCK EQUIVALENTS |
The
Company had the following anti-dilutive common stock equivalents at December, 2025 and 2024:
SCHEDULE
OF ANTI-DILUTIVE COMMON STOCK EQUIVALENTS
| | |
December 31, 2025 | | |
December 31, 2024 | |
| Stock warrants | |
| 1,588,417 | | |
| 1,523,667 | |
| Stock options | |
| 31,838,322 | | |
| 32,493,392 | |
| Unvested restricted stock | |
| 4,988,817 | | |
| 6,278,370 | |
| Convertible notes | |
| 14,863,205 | | |
| 6,063,890 | |
| Preferred stock | |
| 10,999,997 | | |
| 5,500,000 | |
| Anti-dilutive securities | |
| 64,278,758 | | |
| 51,859,319 | |
|